Multi-level insights into the immuno-oncology-microbiome axis: From biotechnology to novel therapies

References

[1] Sepich-Poore, Gregory D., Laurence Zitvogel, Ravid Straussman, Jeff Hasty, Jennifer A. Wargo, and Rob Knight. 2021. “The Microbiome and Human Cancer.” Science 371: eabc4552. https://doi.org/10.1126/science.abc4552

[2] Lu, Ying-Qi, Han Qiao, Xi-Rong Tan, and Na Liu. 2024. “Broadening Oncological Boundaries: The Intratumoral Microbiota.” Trends in Microbiology 32: 807-822. https://doi.org/10.1016/j.tim.2024.01.007

[3] Ghaddar, Bassel, Antara Biswas, Chris Harris, M. Bishr Omary, Darren R. Carpizo, Martin J. Blaser, and Subhajyoti De. 2022. “Tumor Microbiome Links Cellular Programs and Immunity in Pancreatic Cancer.” Cancer Cell 40: 1240-1253.e5. https://doi.org/10.1016/j.ccell.2022.09.009

[4] Xu, Ziye, Yuting Wang, Kuanwei Sheng, Raoul Rosenthal, Nan Liu, Xiaoting Hua, Tianyu Zhang, et al. 2023. “Droplet-Based High-Throughput Single Microbe RNA Sequencing By Smrandom-Seq.” Nature Communications 14: 5130. https://doi.org/10.1038/s41467-023-40137-9

[5] Meng, Hongen, Tianyu Zhang, Zhang Wang, Yuyi Zhu, Yingying Yu, Hangfei Chen, Jiaye Chen, et al. 2024. “High-Throughput Host-Microbe Single-Cell RNA Sequencing Reveals Ferroptosis-Associated Heterogeneity during Acinetobacter baumannii Infection.” Angewandte Chemie International Edition 63: e202400538. https://doi.org/10.1002/anie.202400538

[6] Galeano Niño, Jorge Luis, Hanrui Wu, Kaitlyn D. LaCourse, Andrew G. Kempchinsky, Alexander Baryiames, Brittany Barber, Neal Futran, et al. 2022. “Effect of the Intratumoral Microbiota on Spatial and Cellular Heterogeneity in Cancer.” Nature 611: 810-817. https://doi.org/10.1038/s41586-022-05435-0

[7] Lötstedt, Britta, Martin Stražar, Ramnik Xavier, Aviv Regev, and Sanja Vickovic. 2023. “Spatial Host-Microbiome Sequencing Reveals Niches in the Mouse Gut.” Nature Biotechnology . In press. https://doi.org/10.1038/s41587-023-01988-1

[8] Shi, Hao, Qiaojuan Shi, Benjamin Grodner, Joan Sesing Lenz, Warren R. Zipfel, Ilana Lauren Brito, and Iwijn De Vlaminck. 2020. “Highly Multiplexed Spatial Mapping of Microbial Communities.” Nature 588: 676-681. https://doi.org/10.1038/s41586-020-2983-4

[9] Routy, Bertrand, John G. Lenehan, Wilson H. Miller, Rahima Jamal, Meriem Messaoudene, Brendan A. Daisley, Cecilia Hes, et al. 2023. “Fecal Microbiota Transplantation Plus anti-PD-1 Immunotherapy in Advanced Melanoma: A Phase I Trial.” Nature Medicine 29: 2121-2132. https://doi.org/10.1038/s41591-023-02453-x

[10] Kim, Yunjae, Gihyeon Kim, Sujeong Kim, Beomki Cho, Sang-Yeob Kim, Eun-Ju Do, Dong-Jun Bae, et al. 2024. “Fecal Microbiota Transplantation Improves anti-PD-1 Inhibitor Efficacy in Unresectable or Metastatic Solid Cancers Refractory to Anti-PD-1 Inhibitor.” Cell Host & Microbe 32: 1380-1393. https://doi.org/10.1016/j.chom.2024.06.010

[11] Zhang, Ting, Gaochen Lu, Zhe Zhao, Yafei Liu, Quan Shen, Pan Li, Yaoyao Chen, et al. 2020. “Washed Microbiota Transplantation vs. Manual Fecal Microbiota Transplantation: Clinical Findings, Animal Studies and in Vitro Screening.” Protein & Cell 11: 251-266. https://doi.org/10.1007/s13238-019-00684-8

[12] Fecal Microbiota Transplantation-standardization Study Group. 2020. “Nanjing Consensus on Methodology of Washed Microbiota Transplantation.” Chinese Medical Journal 133: 2330-2332. https://doi.org/10.1097/CM9.0000000000000954

[13] Lu, Gaochen, Weihong Wang, Pan Li, Quan Wen, Bota Cui, and Faming Zhang. 2022. “Washed Preparation of Faecal Microbiota Changes the Transplantation Related Safety, Quantitative Method and Delivery.” Microbial Biotechnology 15: 2439-2449. https://doi.org/10.1111/1751-7915.14074

[14] Halsey, Taylor M., Anusha S. Thomas, Tomo Hayase, Weijie Ma, Hamzah Abu-Sbeih, Baohua Sun, Edwin Roger Parra, et al. 2023. “Microbiome Alteration Via Fecal Microbiota Transplantation is Effective for Refractory Immune Checkpoint Inhibitor-Induced Colitis.” Science Translational Medicine 15: eabq4006. https://doi.org/10.1126/scitranslmed.abq4006

[15] Jia, Dingjiacheng, Qiwen Wang, Yadong Qi, Yao Jiang, Jiamin He, Yifeng Lin, Yong Sun, et al. 2024. “Microbial Metabolite Enhances Immunotherapy Efficacy By Modulating T Cell Stemness in Pan-Cancer.” Cell 187: 1651-1665.e21. https://doi.org/10.1016/j.cell.2024.02.022

[16] Ling, Dandan, Xueli Jia, Ke Wang, Qiucheng Yan, Bochuan Yuan, Lina Du, Miao Li, and Yiguang Jin. 2024. “Cancer Cell Membrane-Coated Bacterial Ghosts for Highly Efficient Paclitaxel Delivery Against Metastatic Lung Cancer.” Acta Pharmaceutica Sinica B 14: 365-377. https://doi.org/10.1016/j.apsb.2023.08.012

[17] Akolpoglu, Mukrime Birgul, Yunus Alapan, Nihal Olcay Dogan, Saadet Fatma Baltaci, Oncay Yasa, Gulsen Aybar Tural, and Metin Sitti. 2022. “Magnetically Steerable Bacterial Microrobots Moving in 3D Biological Matrices for Stimuli-Responsive Cargo Delivery.” Science Advances 8: eabo6163. https://doi.org/10.1126/sciadv.abo6163

[18] Yang, Ye, Yaozhang Yang, Dingyuan Liu, Yuanyuan Wang, Minqiao Lu, Qi Zhang, Jiqing Huang, et al. 2023. “In-Vivo Programmable Acoustic Manipulation of Genetically Engineered Bacteria.” Nature Communications 14: 3297. https://doi.org/10.1038/s41467-023-38814-w

[19] Hahn, Jaeseung, Suwan Ding, Jongwon Im, Tetsuhiro Harimoto, Kam W. Leong, and Tal Danino. 2024. “Bacterial Therapies at the Interface of Synthetic Biology and Nanomedicine.” Nature Reviews Bioengineering 2: 120-135. https://doi.org/10.1038/s44222-023-00119-4

[20] Zepeda-Rivera, Martha, Samuel S. Minot, Heather Bouzek, Hanrui Wu, Aitor Blanco-Míguez, Paolo Manghi, Dakota S. Jones, et al. 2024. “A Distinct Fusobacterium Nucleatum Clade Dominates the Colorectal Cancer Niche.” Nature 628: 424-432. https://doi.org/10.1038/s41586-024-07182-w

RIGHTS & PERMISSIONS

2024 The Author(s). iMeta published by John Wiley & Sons Australia, Ltd on behalf of iMeta Science.